机构:[1]Biotechnology Developing Center of Henan Academy of Sciences, Henan Academy of Sciences, Zhengzhou 450002, Henan, People's Republic of China.[2]State Key Laboratory of Photochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, People's Republic of China[3]Research Division of Clinical Pharmacology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, People's Republic of China江苏省人民医院
The roots and rhizomes of Cimicifuga yunnanensis Hsiao are commonly used as anti-inflammatory, antipyretic, and analgesic remedies and detoxification agents in traditional Chinese medicine (TCM). Although C. yunnanensis has been considered as supplementary medicine for several disorders, the antitumor effect of this herb and its key components has not been explored.The rhizomes of C. yunnanensis were isolated by chromatographic techniques. Structures of isolated compounds were identified based on spectroscopic methods and comparison with published data. The in vitro anticancer activities of purified components were also performed by MTT experiments. The in vivo anticancer activities were examined by subcutaneous tumor model or a breast cancer liver metastasis model.In this study, we aimed to identify and characterize the effective antitumor components from the rhizomes of C. yunnanensis. By bioassay-guided fractionation techniques and chemical characterization, 12 cycloartane triterpenes and four chromones were isolated, among them, 11 compounds were identified in this genus at first. The identified two compounds showed dramatic inhibitory activities against breast cancer cells: compound 4 (23-epi-26-deoxyactein) and compound 13 (cimigenol). Then, we examined the antitumor effect of these two selective candidate chemicals on triple-negative breast cancer (TNBC) cells in vivo and found that they could reduce tumor growth in subcutaneous tumor model or breast cancer liver metastasis model.These results suggested that the selective compounds isolated from C. yunnanensis Hsiao could be the promising new agents for TNBC treatment.
基金:
Natural Science
Foundation (20702055 and 20872148) and Henan
Academy of Sciences Research and Development Project
(10KF13003). We thank Dr Feng at the Research Center for
Clinical and Translational Medicine, 302 Hospital of Chinese
PLA, Beijing, 100039, PR China for his help and advice.
第一作者机构:[1]Biotechnology Developing Center of Henan Academy of Sciences, Henan Academy of Sciences, Zhengzhou 450002, Henan, People's Republic of China.[2]State Key Laboratory of Photochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, People's Republic of China
通讯作者:
通讯机构:[2]State Key Laboratory of Photochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, Yunnan, People's Republic of China[3]Research Division of Clinical Pharmacology, The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, People's Republic of China[*1]State Key Laboratory of Photochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, No. 132 Hei-lan Road, Panlong District, Kunming 650201, Yunnan, People’s Republic of China[*2]Research Division of Clinical Pharmacology, The First Affiliated Hospital, Nanjing Medical University, No. 300 Guangzhou Road, Nanjing 210029, People’s Republic of China
推荐引用方式(GB/T 7714):
Li Xiao,Wang Wei,Fan Yi,et al.Anticancer efficiency of cycloartane triterpenoid derivatives isolated from Cimicifuga yunnanensis Hsiao on triple-negative breast cancer cells[J].CANCER MANAGEMENT AND RESEARCH.2018,10:6715-6729.doi:10.2147/CMAR.S185387.
APA:
Li Xiao,Wang Wei,Fan Yi,Wei Yue,Yu Li-Qin...&Wang Yi-Fen.(2018).Anticancer efficiency of cycloartane triterpenoid derivatives isolated from Cimicifuga yunnanensis Hsiao on triple-negative breast cancer cells.CANCER MANAGEMENT AND RESEARCH,10,
MLA:
Li Xiao,et al."Anticancer efficiency of cycloartane triterpenoid derivatives isolated from Cimicifuga yunnanensis Hsiao on triple-negative breast cancer cells".CANCER MANAGEMENT AND RESEARCH 10.(2018):6715-6729